Literature DB >> 10523510

Phosphatase 2A and polo kinase, two antagonistic regulators of cdc25 activation and MPF auto-amplification.

A Karaïskou1, C Jessus, T Brassac, R Ozon.   

Abstract

The auto-catalytic activation of the cyclin-dependent kinase Cdc2 or MPF (M-phase promoting factor) is an irreversible process responsible for the entry into M phase. In Xenopus oocyte, a positive feed-back loop between Cdc2 kinase and its activating phosphatase Cdc25 allows the abrupt activation of MPF and the entry into the first meiotic division. We have studied the Cdc2/Cdc25 feed-back loop using cell-free systems derived from Xenopus prophase-arrested oocyte. Our findings support the following two-step model for MPF amplification: during the first step, Cdc25 acquires a basal catalytic activity resulting in a linear activation of Cdc2 kinase. In turn Cdc2 partially phosphorylates Cdc25 but no amplification takes place; under this condition Plx1 kinase and its activating kinase, Plkk1 are activated. However, their activity is not required for the partial phosphorylation of Cdc25. This first step occurs independently of PP2A or Suc1/Cks-dependent Cdc25/Cdc2 association. On the contrary, the second step involves the full phosphorylation and activation of Cdc25 and the initiation of the amplification loop. It depends both on PP2A inhibition and Plx1 kinase activity. Suc1-dependent Cdc25/Cdc2 interaction is required for this process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523510     DOI: 10.1242/jcs.112.21.3747

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  27 in total

1.  The role of Plo1 kinase in mitotic commitment and septation in Schizosaccharomyces pombe.

Authors:  K Tanaka; J Petersen; F MacIver; D P Mulvihill; D M Glover; I M Hagan
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

2.  A novel regulatory element determines the timing of Mos mRNA translation during Xenopus oocyte maturation.

Authors:  Amanda Charlesworth; John A Ridge; Leslie A King; Melanie C MacNicol; Angus M MacNicol
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

3.  Multisite phosphorylation and network dynamics of cyclin-dependent kinase signaling in the eukaryotic cell cycle.

Authors:  Ling Yang; W Robb MacLellan; Zhangang Han; James N Weiss; Zhilin Qu
Journal:  Biophys J       Date:  2004-06       Impact factor: 4.033

4.  Functional interaction of Aurora-A and PP2A during mitosis.

Authors:  Virginie Horn; Jacques Thélu; Alphonse Garcia; Corinne Albigès-Rizo; Marc R Block; Jean Viallet
Journal:  Mol Biol Cell       Date:  2007-01-17       Impact factor: 4.138

5.  Suppression of the Schizosaccharomyces pombe cut12.1 cell-cycle defect by mutations in cdc25 and genes involved in transcriptional and translational control.

Authors:  Victor A Tallada; Alan J Bridge; Patrick A Emery; Iain M Hagan
Journal:  Genetics       Date:  2007-04-03       Impact factor: 4.562

6.  Redundant pathways for Cdc2 activation in Xenopus oocyte: either cyclin B or Mos synthesis.

Authors:  Olivier Haccard; Catherine Jessus
Journal:  EMBO Rep       Date:  2005-12-16       Impact factor: 8.807

7.  Phosphorylation of Ran-binding protein-1 by Polo-like kinase-1 is required for interaction with Ran and early mitotic progression.

Authors:  Hyo-In Hwang; Jae-Hoon Ji; Young-Joo Jang
Journal:  J Biol Chem       Date:  2011-08-03       Impact factor: 5.157

8.  Inhibition of Xenopus oocyte meiotic maturation by catalytically inactive protein kinase A.

Authors:  Anja Schmitt; Angel R Nebreda
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

9.  The role of Drosophila CID in kinetochore formation, cell-cycle progression and heterochromatin interactions.

Authors:  M D Blower; G H Karpen
Journal:  Nat Cell Biol       Date:  2001-08       Impact factor: 28.824

10.  Xp38gamma/SAPK3 promotes meiotic G(2)/M transition in Xenopus oocytes and activates Cdc25C.

Authors:  Eusebio Perdiguero; Marie-Jeanne Pillaire; Jean-Francois Bodart; Florian Hennersdorf; Morten Frödin; Nicholas S Duesbery; Gema Alonso; Angel R Nebreda
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.